Showing results (1361-1370 of 2,071) with videos related to

Sort By:
Pageof 208
World Journal of Diabetes|April 29, 2024
Construction and validation of a neovascular glaucoma nomogram in patients with diabetic retinopathy after pars plana vitrectomyYi Shi, Yan-Xin Zhang, Ming-Fei Jiao, et al.
Clinical and Experimental Pharmacology & Physiology|February 2, 2011
Neuroendocrine-immune disorder in type 2 diabetic patients with retinopathyMutallip Obulkasim, Ablikim Turdi, Nurmuhammat Amat, et al.
Biology|September 4, 2025
Forecasting Northward Range Expansion of Switchgrass in China via Multi-Scenario MaxEnt SimulationsYangzhou Xiang, Suhang Li, Qiong Yang, et al.
Disease Models & Mechanisms|June 3, 2015
Understanding the molecular mechanisms of human microtia via a pig model of HOXA1 syndromeRuimin Qiao, Yuyong He, Bo Pan, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 9, 2020
Double knockout of Akt2 and AMPK accentuates high fat diet-induced cardiac anomalies through a cGAS-STING-mediated mechanismYan Gong, Guangwei Li, Jun Tao, et al.
Frontiers in Immunology|August 25, 2025
Case Report: Long-term response control in a patient with metastatic gastric squamous cell carcinoma treated with nivolumab and chemoradiotherapyYu-Ying Lei, Li Li, Ya-Bin Shi, et al.
Acta Biochimica Et Biophysica Sinica|September 23, 2022
Combined cell grafting and VPA administration facilitates neural repair through axonal regeneration and synaptogenesis in traumatic brain injurySujuan Liu, Haili Tian, Yanmei Niu, et al.
Injury|August 22, 2008
Replantation of articular composite tissue masses severed from extremitiesGuo-xian Pei, Gao-hong Ren, Kuan-hai Wei, et al.
Clinical and Experimental Pharmacology & Physiology|October 19, 2007
Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjectsLin-Lin Li, Xiao-Li Ma, Jian-Xin Ran, et al.
Oncology Letters|December 3, 2019
Predictive significance of T cell subset changes during <i>ex vivo</i> generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancerLefu Huang, Guoliang Qiao, Michael A Morse, et al.
Pageof 208